CTChiara La Tessa

Chiara La Tessa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chiara La Tessa has a total of 390 co-authors. Here are the top co-authors by number of shared publications:

  • Marco Durante

    Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Planckstraße 1, 64291, Darmstadt, Germany; Institute of Condensed Matter Physics, Technische Universität Darmstadt, Hochschulstr. 6, 64289, Darmstadt, Germany; Department of Physics "Ettore Pancini", University Federico II, Via Cintia, 21 - Building 6, 80126, Naples, Italy

    21 shared publications
  • Emanuele Scifoni

    Trento Institute for Fundamental Physics and Applications (TIFPA), National Institute for Nuclear Physics (INFN), Trento, Italy

    18 shared publications
  • Francesco Tommasino

    10 shared publications
  • Francesco Cordoni

    Department of Physics University of Trento Trento Italy

    9 shared publications
  • Marta Missiaggia

    Trento Institute for Fundamental Physics and Application (TIFPA) via Sommarive 15 38123 Trento Italy

    9 shared publications
  • Amy J. Wisdom

    Harvard Radiation Oncology Program, Boston, Massachusetts, USA; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

    8 shared publications

Latest Publications

  • Proton-specific dose and radiation quality constraints to reduce acute oral mucositis in head and neck cancer patients

    by Giorgio Cartechini, Laurine Schnelzauer, Francesco Giuseppe Cordoni, Shiyi Liu, Marta Missiaggia, Cyrus Washington, Wei Zhao, Michael Butkus, Stuart Samuels, Chiara La Tessa

  • Open Access

    Editorial: 3 rd international workshop on microdosimetry for particle therapy: Bridging physics and biology

    by Sandra Barna, Valeria Conte, Francesco Cordoni, Marta Missiaggia, Fada Guan, Anatoly Rozenfeld, Gustavo Santa Cruz, Tatsuhiko Sato, Giuseppe Schettino, Chiara La Tessa

  • Microdosimetry investigation of target fragments in proton therapy, assessing the impact of the detector type

    by Gabriele Parisi, Marta Missiaggia, Enrico Pierobon, Francesco G Cordoni, Enrico Verroi, Claudio Verona, Giuseppe Schettino, Chiara La Tessa

    Objective. Proton therapy is increasingly used in oncology due to its enhanced biological effectiveness and precision in targeting tumour tissues. Accurately characterising the radiation quality is, therefore, fundamental. However, the role of fragments in proton therapy remains understudied, mainly due to their low frequency of occurrence and limited impact on the dose. The fragments generated, though, interact differently with biological tissues and may substantially affect the biological response. This work characterises the fragments field generated by a typical clinical proton beam using microdosimetry. Approach. Experiments and Monte Carlo simulations were carried out for this purpose, using a 70.2 MeV proton beam moderated by a lung-equivalent material. Main results. Fragments contributed around 2% to y ¯ F and over 60% to y ¯ D , underscoring their relevance. The detector structure critically influenced their measurement, highlighting the necessity of detector-specific interpretation of spectra when used for biological modelling. Significance. Our results stress the importance of fragment-aware approaches for accurately assessing radiation quality and predicting biological outcomes in proton therapy.

  • Open Access

    A novel methodology to estimate pileup effects and induced error in microdosimetric spectra

    by E. Pierobon, M. Missiaggia, F. G. Cordoni, C. La Tessa

    Microdosimetry provides a superior characterization of the radiation field compared to conventional LET-based methodology, and for this reason it has become increasingly attractive for quality assurance in particle therapy. However, the typical particle rates used in the treatments lead to pileup, which distorts the experimental spectra, and thus compromises the accuracy of microdosimetric measurements, limiting their use in clinical settings. In this work, we investigated the pileup in a spherical Tissue Equivalent Proportional Counter (TEPC), and developed an algorithm to evaluate the contribution of this effect to the measured spectra. We exposed the TEPC to 11 and 70 MeV proton beams, and collected the microdosimetric spectra at rates in the $10^3$-$10^6$ pps range. Using a combination of GEANT4 Monte Carlo simulations and experimental data, we develop an algorithm capable of estimating the pileup probability affecting experimental measurements. The data suggest that the pileup probability has a linear increase with rate until it reaches a value of $15 \pm 3 \, \%$ at $28.2 \times 10^3$ pps, at which point it begins to saturate. Additionally, the outcomes from the comparison of the two proton energies suggest that the methodology used to estimate pileup can be used to predict the effects in clinical proton beams with similar energies. This same methodology can be applied to any type of microdosimetric measurement making it a reliable tool for addressing pileup issues and facilitating the application of microdosimetry in clinical settings.

  • Open Access

    Validation of the generalized stochastic microdosimetric model (GSM 2 ) over a broad range of LET and particle beam type: a unique model for accurate description of (therapy relevant) radiation qualities

    by Giulio Bordieri, Marta Missiaggia, Giorgio Cartechini, Marco Battestini, Lawrence Bronk, Fada Guan, David Grosshans, Priyamvada Rai, Emanuele Scifoni, Chiara La Tessa, et al.

    Objective. The present work shows the first extensive validation of the generalized stochastic microdosimetric model (GSM2). This mechanistic and probabilistic model is trained and tested over cell survival experiments conducted with two cell lines (H460 and H1437), three different types of radiation (protons, helium, and carbon ions), spanning a very broad LET range from 1   keV μ m − 1 up to more than 300   keV μ m − 1 . Currently, the existing mechanistic radiation biophysical models show some limitations in describing cell killing without the addition of ad hoc corrections, especially in the high-LET regime, where the overkill effect is observed. Approach. The experimental irradiation conditions have been accurately reproduced with Monte Carlo simulations using the GEANT4-based TOPAS computational toolkit. We show the main and unique features of GSM 2 , i.e. how it can predict the biological response by considering the full information on the stochasticity of radiation through the microdosimetric spectrum, which is supposed to be the best descriptor of radiation quality. Main results. Well-matching results for different biological endpoints with the natural presence of the overkill effect fully display the predictive power of GSM2. Significance. This study shows the complete generality and flexibility of GSM2 and its ability to successfully predict the cell survival probability from very different particle radiation fields. Consequently, we demonstrate the dependence of the relative biological effectiveness on the whole microdosimetric spectrum, which fully includes the stochasticity inherently given by radiation-matter interaction.


  • Open Access

    Integrating microdosimetric in vitro RBE models for particle therapy into TOPAS MC using the MicrOdosimetry-based modeliNg for RBE ASsessment (MONAS) tool

    by Giorgio Cartechini, Marta Missiaggia, Emanuele Scifoni, Chiara La Tessa, Francesco G Cordoni

    Objective. In this paper, we present MONAS (MicrOdosimetry-based modelliNg for relative biological effectiveness (RBE) ASsessment) toolkit. MONAS is a TOPAS Monte Carlo extension, that combines simulations of microdosimetric distributions with radiobiological microdosimetry-based models for predicting cell survival curves and dose-dependent RBE. Approach. MONAS expands TOPAS microdosimetric extension, by including novel specific energy scorers to calculate the single- and multi-event specific energy microdosimetric distributions at different micrometer scales. These spectra are used as physical input to three different formulations of the microdosimetric kinetic m odel , and to the generalized stochastic microdosimetric model (GSM 2 ), to predict dose-dependent cell survival fraction and RBE. MONAS predictions are then validated against experimental microdosimetric spectra and in vitro survival fraction data. To show the MONAS features, we present two different applications of the code: (i) the depth-RBE curve calculation from a passively scattered proton SOBP and monoenergetic 12 C-ion beam by using experimentally validated spectra as physical input, and (ii) the calculation of the 3D RBE distribution on a real head and neck patient geometry treated with protons. Main results. MONAS can estimate dose-dependent RBE and cell survival curves from experimentally validated microdosimetric spectra with four clinically relevant radiobiological models. From the radiobiological characterization of a proton SOBP and 12 C fields, we observe the well-known trend of increasing RBE values at the distal edge of the radiation field. The 3D RBE map calculated confirmed the trend observed in the analysis of the SOBP, with the highest RBE values found in the distal edge of the target. Significance. MONAS extension offers a comprehensive microdosimetry-based framework for assessing the biological effects of particle radiation in both research and clinical environments, pushing closer the experimental physics-based description to the biological damage assessment, contributing to bridging the gap between a microdosimetric description of the radiation field and its application in proton therapy treatment with variable RBE.


  • Microdosimetric analysis of the radiation quality of two different proton beams in the distal edge of the depth-dose profile

    by A Bianchi, A Selva, M Rossignoli, F Pasquato, M Missiaggia, C La Tessa, E Scifoni, F Tommasino, V Conte

    Proton-therapy exploits the advantageous depth-dose profile of protons to induce the highest damage to tumoral cells in the last millimetres of their range in sharp Bragg Peak. To cover the whole tumoral volume, beams of different energies are combined to create the Spread Out Bragg Peak (SOBP). In passive modulated beams, the energy spread is created with modulators in which the highest energy beam is degraded through different thicknesses of calibrated plastic materials. The highest energy is chosen depending on the deepest point that needs to be treated. This study aims to investigate differences in the radiation quality in the distal edge of SOBP beams with different initial energy and modulation techniques based on microdosimetric measurements with mini Tissue-Equivalent Proportional Counters. The beams investigated are the 62 MeV proton SOBP of the clinical facility of CATANA and the 148 MeV proton SOBP of the research beam line of the proton-therapy centre of Trento.

  • Open Access

    An artificial intelligence-based model for cell killing prediction: development, validation and explainability analysis of the ANAKIN model

    by Francesco G Cordoni, Marta Missiaggia, Emanuele Scifoni, Chiara La Tessa

    The present work develops ANAKIN: an Artificial iNtelligence bAsed model for (radiation-induced) cell KIlliNg prediction . ANAKIN is trained and tested over 513 cell survival experiments with different types of radiation contained in the publicly available PIDE database. We show how ANAKIN accurately predicts several relevant biological endpoints over a wide broad range on ion beams and for a high number of cell-lines. We compare the prediction of ANAKIN to the only two radiobiological models for Relative Biological Effectiveness prediction used in clinics, that is the Microdosimetric Kinetic Model and the Local Effect Model (LEM version III), showing how ANAKIN has higher accuracy over the all considered cell survival fractions. At last, via modern techniques of Explainable Artificial Intelligence (XAI), we show how ANAKIN predictions can be understood and explained, highlighting how ANAKIN is in fact able to reproduce relevant well-known biological patterns, such as the overkilling effect.


  • Open Access

    Supplementary Figure 1 from Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma

    by Jeremy M. Brownstein, Amy J. Wisdom, Katherine D. Castle, Yvonne M. Mowery, Peter Guida, Chang-Lung Lee, Francesco Tommasino, Chiara La Tessa, Emanuele Scifoni, Junheng Gao, et al.

    Comparing the effect anesthetic agent and housing location on tumor quintupling. A) Tumor quintupling times in mice treated with 20 Gy X-rays who were anesthetized with ketamine/xylazine vs. isoflurane, demonstrating no significant differences. B) Tumor quintupling time in untreated controls followed at Brookhaven National Laboratory vs. Duke University Medical Center, demonstrating no significant differences.